

over 7 years ago // Devex World: Sponsored by USP
New research has found that 13.6 percent of medicines in low- and middle-income countries are falsified or substandard, acting as an impediment to progress in global disease prevention and treatment. USP's Emily Kaine explains how this can be tackled.